Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taff Jones

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Molecular Therapeutics|October 8, 2004
Technology evaluation: ChimeriVax-DEN, Acambis/AventisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
StaphVAX (Nabi)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Hepagene (PowderJect)Taff Jones
Current Opinion in Molecular Therapeutics|August 7, 2008
IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infectionTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Varivax (Merck & Co)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Peru-1 5 (AVANT)Taff Jones
Idrugs : the Investigational Drugs Journal|July 27, 2005
Boostrix (GlaxoSmithKline)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|August 20, 2010
Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infectionTaff Jones
Current Opinion in Molecular Therapeutics|May 30, 2009
GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infectionTaff Jones
Expert Review of Vaccines|October 16, 2004
Vaccines to remember: managing health in our twilight yearsTaff Jones
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|October 8, 2004
Technology evaluation: ChimeriVax-DEN, Acambis/AventisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
StaphVAX (Nabi)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Hepagene (PowderJect)Taff Jones
Current Opinion in Molecular Therapeutics|August 7, 2008
IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infectionTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Varivax (Merck & Co)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|December 17, 2004
Peru-1 5 (AVANT)Taff Jones
Idrugs : the Investigational Drugs Journal|July 27, 2005
Boostrix (GlaxoSmithKline)Taff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|August 20, 2010
Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infectionTaff Jones
Current Opinion in Molecular Therapeutics|May 30, 2009
GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infectionTaff Jones
Expert Review of Vaccines|October 16, 2004
Vaccines to remember: managing health in our twilight yearsTaff Jones
Pageof 3